Advances in drug delivery for articular cartilage

Journal of Controlled Release

Volumn 86, Issue 1, 2003, Pages 1-14

  Holland, Theresa A ^a   Mikos, Antonios G ^a  

^a Rice University   (United States)

Author keywords

Articular cartilage; Controlled release; Cytokine; Drug delivery; Growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; GROWTH PROMOTOR;

ARTICULAR CARTILAGE; CARTILAGE CELL; CELL ACTIVITY; CONNECTIVE TISSUE; DEGRADATION; DRUG DELIVERY SYSTEM; EXTRACELLULAR MATRIX; INFLAMMATION; JOINT; METABOLISM; MOLECULE; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; TISSUE REPAIR; ANIMAL; DRUG EFFECT; HUMAN; METHODOLOGY; NON-PROGRAMMATIC; OSTEOCHONDRITIS; PATHOLOGY;

NON-PROGRAMMATIC;

ANIMALS; CARTILAGE, ARTICULAR; CYTOKINES; DRUG DELIVERY SYSTEMS; GROWTH SUBSTANCES; HUMANS; OSTEOCHONDRITIS;

EID: 0037426699     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00373-5     Document Type: Review

References (114)

1. Gillogly S.D., Voight M., Blackburn T. Treatment of articular cartilage defects of the knee with autologous chondrocyte implantation. J. Orthop. Sports Phys. Ther. 28:1998;241-251.
2. Hunziker E.B. Articular cartilage repair: are the intrinsic biological constraints undermining this process insuperable? Osteoarthritis Cartilage. 7:1999;15-28.
3. LeBaron R.G., Athanasiou K.A. Ex vivo synthesis of articular cartilage. Biomaterials. 21:2000;2575-2587.
4. Stockwell R.A. Biology of Cartilage Cells. 1979;Cambridge University Press, New York.
5. Rosier R.N., O'Keefe R.J. Autocrine regulation of articular cartilage. AAOS Instr. Course Lect. 47:1998;469-475.
6. Annefeld M. The Chondrocyte - The Living Element of Articular Cartilage. 1983;Hans Huber, Bern.
7. Silver F.H., Glasgold A.I. Cartilage wound healing. An overview. Otolaryngol. Clin. North Am. 28:1995;847-864.
8. Wirth C.J., Rudert M. Techniques of cartilage growth enhancement: a review of the literature. Arthroscopy. 12:1996;300-308.
9. Demoor-Fossard M., Galera P., Santra M., Iozzo R.V., Pujol J.P., Redini F. A composite element binding the vitamin D receptor and the retinoic X receptor alpha mediates the transforming growth factor-beta inhibition of decorin gene expression in articular chondrocytes. J. Biol. Chem. 276:2001;36983-36992.
10. Seyedin S.M., Rosen D.M., Segarini P.R. Modulation of chondroblast phenotype by transforming growth factor-beta. Pathol. Immunopathol. Res. 7:1988;38-42.
11. Xie D., Hui F., Homandberg G.A. Fibronectin fragments alter matrix protein synthesis in cartilage tissue cultured in vitro. Arch. Biochem. Biophys. 307:1993;110-118.
12. Nguyen Q., Murphy G., Hughes C.E., Mort J.S., Roughley P.J. Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem. J. 295:(Pt 2):1993;595-598.
13. Clark I.M., Murphy G. Matrix proteinases. Seibel M.J., Robins S.P., Bilezikian J.P. Dynamics of Bone and Cartilage Metabolism. 1999;137-150 Academic Press, New York.
14. Martel-Pelletier J., McCollum R., Fujimoto N., Obata K., Cloutier J.M., Pelletier J.P. Excess of metalloproteases over tissue inhibitor of metalloproteases may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab. Invest. 70:1994;807-815.
15. Pimentel E. Handbook of Growth Factors: General Basic Aspects. Vol. 1:1994;CRC Press, Boca Raton, FL.
16. Nimni M.E. Polypeptide growth factors: targeted delivery systems. Biomaterials. 18:1997;1201-1225.
17. Martin J.A., Buckwalter J.A. The role of chondrocyte-matrix interactions in maintaining and repairing articular cartilage. Biorheology. 37:2000;129-140.
18. Hauselmann H.J. Mechanisms of cartilage destruction and novel nonsurgical therapeutic strategies to retard cartilage injury in rheumatoid arthritis. Curr. Opin. Rheumatol. 9:1997;241-250.
19. Pimentel E. Handbook of Growth Factors: Peptide Growth Factors. Vol. 2:1994;CRC Press, Boca Raton, FL.
20. Sporn M.B., Roberts A.B., Wakefield L.M., Assoian R.K. Transforming growth factor-beta: biological function and chemical structure. Science. 233:1986;532-534.
21. Border W.A., Noble N.A. Transforming growth factor beta in tissue fibrosis. New Engl. J. Med. 331:1994;1286-1292.
22. Olofsson A., Miyazono K., Kanzaki T., Colosetti P., Engstrom U., Heldin C.H. Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J. Biol. Chem. 267:1992;19482-19488.
23. Seyedin S.M., Segarini P.R., Rosen D.M., Thompson A.Y., Bentz H., Graycar J. Cartilage-inducing factor-B is a unique protein structurally and functionally related to transforming growth factor-beta. J. Biol. Chem. 262:1987;1946-1949.
24. Seyedin S.M., Thompson A.Y., Bentz H., Rosen D.M., McPherson J.M., Conti A., Siegel N.R., Galluppi G.R., Piez K.A. Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J. Biol. Chem. 261:1986;5693-5695.
25. Flaumenhaft R., Abe M., Sato Y., Miyazono K., Harpel J., Heldin C.H., Rifkin D.B. Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells. J. Cell Biol. 120:1993;995-1002.
26. Pedrozo H.A., Schwartz Z., Gomez R., Ornoy A., Xin-Sheng W., Dallas S.L., Bonewald L.F., Dean D.D., Boyan B.D. Growth plate chondrocytes store latent transforming growth factor (TGF)-beta 1 in their matrix through latent TGF-beta 1 binding protein-1. J. Cell Physiol. 177:1998;343-354.
27. Ringe J., Kaps C., Schmitt B., Buscher K., Bartel J., Smolian H., Schultz O., Burmester G.R., Haupl T., Sittinger M. Porcine mesenchymal stem cells, induction of distinct mesenchymal lineages. Cell Tissue Res. 307:2002;321-327.
28. Iwasaki M., Nakata K., Nakahara H., Nakase T., Kimura T., Kimata K., Caplan A.I., Ono K. Transforming growth factor-beta 1 stimulates chondrogenesis and inhibits osteogenesis in high density culture of periosteum-derived cells. Endocrinology. 132:1993;1603-1608.
29. Majumdar M.K., Banks V., Peluso D.P., Morris E.A. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J. Cell Physiol. 185:2000;98-106.
30. Joyce M.E., Roberts A.B., Sporn M.B., Bolander M.E. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol. 110:1990;2195-2207.
31. Cassiede P., Dennis J.E., Ma F., Caplan A.I. Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro. J. Bone Miner. Res. 11:1996;1264-1273.
32. Morales T.I. Transforming growth factor-beta 1 stimulates synthesis of proteoglycan aggregates in calf articular cartilage organ cultures. Arch. Biochem. Biophys. 286:1991;99-106.
33. Morales T.I. The role and content of endogenous insulin-like growth factor-binding proteins in bovine articular cartilage. Arch. Biochem. Biophys. 343:1997;164-172.
34. Venn G., Lauder R.M., Hardingham T.E., Muir H. Effects of catabolic and anabolic cytokines on proteoglycan biosynthesis in young, old and osteoarthritic canine cartilage. Biochem. Soc. Trans. 18:1990;973-974.
35. van Beuningen H.M., van der Kraan P.M., Arntz O.J., van den Berg W.B. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab. Invest. 71:1994;279-290.
36. Rosier R.N., O'Keefe R.J., Crabb I.D., Puzas J.E. Transforming growth factor beta: an autocrine regulator of chondrocytes. Connect. Tissue Res. 20:1989;295-301.
37. Vivien D., Galera P., Lebrun E., Loyau G., Pujol J.P. Differential effects of transforming growth factor-beta and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes. J. Cell Physiol. 143:1990;534-545.
38. Xu C., Oyajobi B.O., Frazer A., Kozaci L.D., Russell R.G., Hollander A.P. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures. Endocrinology. 137:1996;3557-3565.
39. Hui W., Rowan A.D., Cawston T. Transforming growth factor beta1 blocks the release of collagen fragments from bovine nasal cartilage stimulated by oncostatin M in combination with IL-1alpha. Cytokine. 12:2000;765-769.
40. Lum Z.P., Hakala B.E., Mort J.S., Recklies A.D. Modulation of the catabolic effects of interleukin-1 beta on human articular chondrocytes by transforming growth factor-beta. J. Cell Physiol. 166:1996;351-359.
41. Hulth A., Johnell O., Miyazono K., Lindberg L., Heinegard D., Heldin C.H. Effect of transforming growth factor-beta and platelet-derived growth factor-BB on articular cartilage in rats. J. Orthop. Res. 14:1996;547-553.
42. van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., van den Berg W.B. Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage. 6:1998;306-317.
43. Uchino M., Izumi T., Tominaga T., Wakita R., Minehara H., Sekiguchi M., Itoman M. Growth factor expression in the osteophytes of the human femoral head in osteoarthritis. Clin. Orthop. 377:2000;119-125.
44. Crabb I.D., O'Keefe R.J., Puzas J.E., Rosier R.N. Synergistic effect of transforming growth factor beta and fibroblast growth factor on DNA synthesis in chick growth plate chondrocytes. J. Bone Miner. Res. 5:1990;1105-1112.
45. Inoue H., Kato Y., Iwamoto M., Hiraki Y., Sakuda M., Suzuki F. Stimulation of cartilage-matrix proteoglycan synthesis by morphologically transformed chondrocytes grown in the presence of fibroblast growth factor and transforming growth factor-beta. J. Cell Physiol. 138:1989;329-337.
46. Elford P.R., Lamberts S.W. Contrasting modulation by transforming growth factor-beta-1 of insulin-like growth factor-I production in osteoblasts and chondrocytes. Endocrinology. 127:1990;1635-1639.
47. Luyten F.P., Chen P., Paralkar V., Reddi A.H. Recombinant bone morphogenetic protein-4, transforming growth factor-beta 1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro. Exp. Cell Res. 210:1994;224-229.
48. Kaps C., Bramlage C., Smolian H., Haisch A., Ungethum U., Burmester G.R., Sittinger M., Gross G., Haupl T. Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. Arthritis Rheum. 46:2002;149-162.
49. Sekiya I., Colter D.C., Prockop D.J. BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem. Biophys. Res. Commun. 284:2001;411-418.
50. Loredo G.A., MacDonald M.H., Benton H.P. Regulation of glycosaminoglycan metabolism by bone morphogenetic protein-2 in equine cartilage explant cultures. Am. J. Vet. Res. 57:1996;554-559.
51. Glansbeek H.L., van Beuningen H.M., Vitters E.L., Morris E.A., van der Kraan P.M., van den Berg W.B. Bone morphogenetic protein 2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract interleukin-1alpha effects on proteoglycan synthesis and content. Arthritis Rheum. 40:1997;1020-1028.
52. Luyten F.P., Hascall V.C., Nissley S.P., Morales T.I., Reddi A.H. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. Arch. Biochem. Biophys. 267:1988;416-425.
53. Gooch K.J., Blunk T., Courter D.L., Sieminski A.L., Bursac P.M., Vunjak-Novakovic G., Freed L.E. IGF-I and mechanical environment interact to modulate engineered cartilage development. Biochem. Biophys. Res. Commun. 286:2001;909-915.
54. Fukumoto T., Sanyal A., Fitzsimmons J., O'Driscoll S. Differential effects of IGF-I, bFGF and TGF- on proliferation and type II collagen mRNA expression during periosteal chondrogenesis. Trans. Orthop. Res. Soc. 25:2000;1056.
55. Hunziker E.B., Wagner J., Zapf J. Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. J. Clin. Invest. 93:1994;1078-1086.
56. O'Keefe R.J., Crabb I.D., Puzas J.E., Rosier R.N. Effects of transforming growth factor-beta 1 and fibroblast growth factor on DNA synthesis in growth plate chondrocytes are enhanced by insulin-like growth factor-I. J. Orthop. Res. 12:1994;299-310.
57. Loeser R.F. Chondrocyte integrin expression and function. Biorheology. 37:2000;109-116.
58. Martin J.A., Buckwalter J.A. Effects of fibronectin on articular cartilage chondrocyte proteoglycan synthesis and response to insulin-like growth factor-I. J. Orthop. Res. 16:1998;752-757.
59. Conover C.A., Clarkson J.T., Bale L.K. Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action. Endocrinology. 137:1996;2286-2292.
60. Vincent T., Hermansson M., Bolton M., Wait R., Saklatvala J. Basic FGF mediates an immediate response of articular cartilage to mechanical injury. Proc. Natl. Acad. Sci. USA. 99:2002;8259-8264.
61. Tamura T., Nakanishi T., Kimura Y., Hattori T., Sasaki K., Norimatsu H., Takahashi K., Takigawa M. Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology. 137:1996;3729-3737.
62. Cuevas P., Burgos J., Baird A. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem. Biophys. Res. Commun. 156:1988;611-618.
63. Shida J., Jingushi S., Izumi T., Iwaki A., Sugioka Y. Basic fibroblast growth factor stimulates articular cartilage enlargement in young rats in vivo. J. Orthop. Res. 14:1996;265-272.
64. Froger-Gaillard B., Charrier A.M., Thenet S., Ronot X., Adolphe M. Growth-promoting effects of acidic and basic fibroblast growth factor on rabbit articular chondrocytes aging in culture. Exp. Cell Res. 183:1989;388-398.
65. Bradham D.M., Horton W.E. Jr. In vivo cartilage formation from growth factor modulated articular chondrocytes. Clin. Orthop. 352:1998;239-249.
66. Posever J., Phillips F.M. L.A, Pottenger L.A. Effects of basic fibroblast growth factor, transforming growth factor-beta 1, insulin-like growth factor-1, and insulin on human osteoarthritic articular cartilage explants. J. Orthop. Res. 13:1995;832-837.
67. Sah R.L., Chen A.C., Grodzinsky A.J., Trippel S.B. Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants. Arch. Biochem. Biophys. 308:1994;137-147.
68. Borden P., Solymar D., Sucharczuk A., Lindman B., Cannon P., Heller R.A. Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes. J. Biol. Chem. 271:1996;23577-23581.
69. Pimentel E. Handbook of Growth Factors: Hematopoietic Growth Factors and Cytokines. Vol. 3:1994;CRC Press, Boca Raton, FL.
70. Jakob M., Demarteau O., Schafer D., Hintermann B., Dick W., Heberer M., Martin I. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J. Cell Biochem. 81:2001;368-377.
71. Pfander D., Kortje D., Zimmermann R., Weseloh G., Kirsch T., Gesslein M., Cramer T., Swoboda B. Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann. Rheum. Dis. 60:2001;1070-1073.
72. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5:1999;623-628.
73. Moos V., Sieper E.J., Herzog V., Muller B. Regulation of expression of cytokines and growth factors in osteoarthritic cartilage explants. Clin. Rheumatol. 20:2001;353-358.
74. Guerne P.A., Carson D.A., Lotz M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J. Immunol. 144:1990;499-505.
75. Cai L., Yin J.P., Starovasnik M.A., Hogue D.A., Hillan K.J., Mort J.S., Filvaroff E.H. Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. Cytokine. 16:2001;10-21.
76. Fosang A.J., Tyler J.A., Hardingham T.E. Effect of interleukin-1 and insulin like growth factor-1 on the release of proteoglycan components and hyaluronan from pig articular cartilage in explant culture. Matrix. 11:1991;17-24.
77. Sasaki K., Hattori T., Fujisawa T., Takahashi K., Inoue H., Takigawa M. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J. Biochem. (Tokyo). 123:1998;431-439.
78. Olee T., Hashimoto S., Quach J., Lotz M. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J. Immunol. 162:1999;1096-1100.
79. Shingu M., Miyauchi S., Nagai Y., Yasutake C., Horie K. The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation. Br. J. Rheumatol. 34:1995;101-106.
80. Patel I.R., Attur M.G., Patel R.N., Stuchin S.A., Abagyan R.A., Abramson S.B., Amin A.R. TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha. J. Immunol. 160:1998;4570-4579.
81. Wilbrink B., Nietfeld J.J., den Otter W., van Roy J.L., Bijlsma J.W., Huber-Bruning O. Role of TNF alpha, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage. Br. J. Rheumatol. 30:1991;265-271.
82. D.W. Jackson, T.M. Simon, Tissue engineering principles in orthopaedic surgery, Clin. Orthop. 367S (1999) S31-45.
83. Coutts R.D., Sah R.L., Amiel D. Effects of growth factors on cartilage repair. AAOS Instr. Course Lect. 46:1997;487-494.
84. Minas T. The role of cartilage repair techniques, including chondrocyte transplantation, in focal chondral knee damage. AAOS Instr. Course Lect. 48:1999;629-643.
85. Homandberg G.A., Hui F. High concentrations of fibronectin fragments cause short-term catabolic effects in cartilage tissue while lower concentrations cause continuous anabolic effects. Arch. Biochem. Biophys. 311:1994;213-218.
86. Homandberg G.A., Hui F. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments. Arch. Biochem. Biophys. 334:1996;325-331.
87. Hui W., Rowan A.D., Cawston T. Modulation of the expression of matrix metalloproteinase and tissue inhibitors of metalloproteinases by TGF-beta1 and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-alpha. Cytokine. 16:2001;31-35.
88. Bullough P.G., Jones W.A., Owen R. CD Atlas of Orthopaedics. 1997;Mosby International, London.
89. Boyan B.D., Lohmann C.H., Romero J., Schwartz Z. Bone and cartilage tissue engineering. Clin. Plast. Surg. 26:(ix):1999;629-645.
90. Brooks P.M., Day R.O. Nonsteroidal antiinflammatory drugs - differences and similarities. New Engl. J. Med. 324:1991;1716-1725.
91. van de Loo F.A., Joosten L.A., van Lent P.L., Arntz O.J., van den Berg W.B. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum. 38:1995;164-172.
92. Hauselmann H.J., Flechtenmacher J., Michal L., Thonar E.J., Shinmei M., Kuettner K.E., Aydelotte M.B. The superficial layer of human articular cartilage is more susceptible to interleukin-1-induced damage than the deeper layers. Arthritis Rheum. 39:1996;478-488.
93. Campion G.V., Lebsack M.E., Lookabaugh J., Gordon G., Catalano M. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group. Arthritis Rheum. 39:1996;1092-1101.
94. Glansbeek H.L., van Beuningen H.M., Vitters E.L., van der Kraan P.M., van den Berg W.B. Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-beta into murine knee joints. Lab. Invest. 78:1998;133-142.
95. van den Berg W.B., van der Kraan P.M., Scharstuhl A., van Beuningen H.M. Tissue engineering, cells, scaffolds, and growth factors. Clin. Orthop. 391S:2001;S244-S250.
96. Martin J.A., Scherb M.B., Lembke L.A., Buckwalter J.A. Damage control mechanisms in articular cartilage: the role of the insulin-like growth factor I axis. Iowa Orthop. J. 20:2000;1-10.
97. Athanasiou K.A., Schenck R., Constantinides V., Sylvia V.L., Aulfdemorte T., Boyan B.D. Biodegradable carriers of TGF-beta in rabbit osteochondral defects. Trans. Orthop. Res. Soc. 18:1993;288.
98. Athanasiou K.A., Korvick D., Schenck R. Biodegradable implants for the treatment of osteochondral defects in a goat model. Tissue Eng. 3:1997;363-373.
99. Fujisato T., Sajiki T., Liu Q., Ikada Y. Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collagen sponge scaffold. Biomaterials. 17:1996;155-162.
100. Bragdon B., Bertone A.L., Hardy J., Simmons E.J., Weisbrode S.E. Use of an isolated joint model to detect early changes induced by intra-articular injection of paclitaxel-impregnated polymeric microspheres. J. Invest. Surg. 14:2001;169-182.
101. Kim M.R., Park T.G. Temperature-responsive and degradable hyaluronic acid/Pluronic composite hydrogels for controlled release of human growth hormone. J. Control. Release. 80:2002;69-77.
102. Sellers R.S., Peluso D., Morris E.A. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J. Bone Joint Surg. Am. 79:1997;1452-1463.
103. E.B. Hunziker, I.M. Driesang, C. Saager, Structural barrier principle for growth factor-based articular cartilage repair, Clin. Orthop. 391S (2001) S182-189.
104. Lu L., Stamatas G.N., Mikos A.G. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J. Biomed. Mater. Res. 50:2000;440-451.
105. Elisseeff J., McIntosh W., Fu K., Blunk B.T., Langer R. Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J. Orthop. Res. 19:2001;1098-1104.
106. Boyan B.D., Lohmann C.H., Somers A., Niederauer G.G., Wozney J.M., Dean D.D., Carnes D.L. Jr., Schwartz Z. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo. J. Biomed. Mater. Res. 46:1999;51-59.
107. Mattioli-Belmonte M., Gigante A., Muzzarelli R.A., Politano R., De Benedittis A., Specchia N., Buffa A., Biagini G., Greco F. N,N-Dicarboxymethyl chitosan as delivery agent for bone morphogenetic protein in the repair of articular cartilage. Med. Biol. Eng. Comp. 37:1999;130-134.
108. Horisawa E., Hirota T., Kawazoe S., Yamada J., Yamamoto H., Takeuchi H., Kawashima Y. Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit. Pharm. Res. 19:2002;403-410.
109. Andrews H.J., Plumpton T.A., Harper G.P., Cawston T.E. A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions. 37:1992;147-154.
110. Wang H., Convery J., Ryaby J.T. TP508, a synthetic thrombin peptide, activates genes that assist fracture healing. Trans. Orthop. Res. Soc. 27:2002;234.
111. Karnaugh R.D., Ryaby J.T., Razzano P., Crowther R.A., Carney D.H., Wu D., Dines D.M., Grande D. In vivo evaluation of the synthetic thrombin peptide, TP508, in articular cartilage. Trans. Orthop. Res. Soc. 27:2002;447.
112. E.L. Hedberg, A. Tang, R.S. Crowther, D.H. Carney, A.G. Mikos, Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites, J. Control. Release (in press).
113. Hunziker E.B., Rosenberg L.C. Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J. Bone Joint Surg. Am. 78:1996;721-733.
114. E.B. Hunziker, I.M. Driesang, E.A. Morris, Chondrogenesis in cartilage repair is induced by members of the transforming growth factor-beta superfamily, Clin. Orthop. 391S (2001) S171-181.